WG
CGON icon

Winton Group’s CG Oncology CGON Stock Holding History

Winton Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Buy
+10,100
New +$660K 0.02% 593
2025
Q3 		– Sell
-8,669
Closed -$225K – 762
2025
Q2 		$225K Buy
+8,669
New +$209K 0.01% 733

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winton Group's CGON Position: Q2 2026 in Review

Winton Group opened a new position in CG Oncology (CGON) in Q2 2026: 10,100 shares worth $718K. The stake represents 0.02% of the portfolio and ranks #593 among its holdings. This is a return to the name: Winton Group previously reported a position in CGON as recently as Q2 2025.

Winton Group first reported a position in CGON in Q2 2025 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Winton Group held 10,100 shares of CG Oncology worth $718K as of Q2 2026.
  • CG Oncology was a new Winton Group position in Q2 2026.
  • CG Oncology made up 0.02% of Winton Group's portfolio in Q2 2026, its #593 holding.
  • Winton Group first reported a position in CG Oncology in Q2 2025 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.